Our data had clearly suggested that aspirin monotherapy significantly suppressed tumor growth and metastasis, and its combined application with 5-Fu potentiated the antitumor effects of 5-Fu in chemoresistant CRC cells through targeting NF-κB and its downstream targets, without increasing AEs. Here, NFKB1 is linked to neoplasm.